Jump to content

Orticumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 20:02, 27 March 2020 (added FDA UNII to drug box). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Orticumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetoxLDL
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.[1]

References

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Orticumab&oldid=947674684"